1-(cyclopentyloxy)-4-nitrobenzene | 26455-35-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(cyclopentyloxy)-4-nitrobenzene
• 英文别名: 1-cyclopentyloxy-4-nitrobenzene
• CAS: 26455-35-6
• 化学式: C₁₁H₁₃NO₃
• 分子量: 207.229
• InChiKey: VXICHIXNGDQYGT-UHFFFAOYSA-N

物化性质

• 沸点：
  343.1±15.0 °C(Predicted)
• 密度：
  1.218±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  55
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-(cyclopentyloxy)-4-nitrobenzene 在 溶剂黄146 、 tin(ll) chloride 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 7.0h， 生成 1-(4-((4-(cyclopentyloxy)phenyl)amino)quinazolin-6-yl)-3-(3,5-difluorophenyl)thiourea
  参考文献：
  名称：

  From EGFR kinase inhibitors to anti-inflammatory drugs: Optimization and biological evaluation of (4-(phenylamino)quinazolinyl)-phenylthiourea derivatives as novel NF-κB inhibitors

  摘要：

  DOI：

  10.1016/j.bioorg.2022.105977
• 作为产物：
  描述：

  溴代环戊烷 、 对硝基苯酚 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 5.0h， 生成 1-(cyclopentyloxy)-4-nitrobenzene
  参考文献：
  名称：

  晶体学引导发现基于咔唑的视黄酸相关孤儿受体 γ-t (RORγt) 调节剂：深入了解“短”和“长”反向激动剂的不同蛋白质行为

  摘要：

  在“短”反向激动剂的晶体学特征的指导下，通过 6 位修饰发现了一系列基于 6 位取代的咔唑的视黄酸相关孤儿受体 γ-t (RORγt) 调节剂6 。随着6位取代基尺寸的增加，“短”反向激动剂6首先将其功能反转为激动剂，然后反转为“长”反向激动剂。通过X射线分析揭示了RORγt与代表性“短”反向激动剂6 （PDB：6LOB）、激动剂7d （PDB：6LOA）和“长”反向激动剂7h （PDB：6LO9）复合的共晶结构。然而，“短”反向激动剂6和“长”反向激动剂7h的结合模式存在微小差异。为了进一步揭示不同RORγt反向激动剂的分子机制，我们进行了分子动力学模拟，发现“短”或“长”反向激动剂导致RORγt螺旋H11、H11'和H12的不同行为。 “短”反向激动剂6使 H11' 不稳定并使 H12 脱位，而“长”反向激动剂7h分离H11 并使 H12 解旋。结果表明，两种类型的反向激动剂在下游信号

  DOI：

  10.1038/s41401-020-00552-w

文献信息

• [EN] CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS DE LA CÉRAMIDE GALACTOSYLTRANSFÉRASE POUR LE TRAITEMENT DE MALADIES
  申请人：BIOMARIN PHARM INC

  公开号：WO2017214505A1

  公开（公告）日：2017-12-14

  Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

  本文描述了化合物、制备这种化合物的方法、含有这种化合物的药物组合物和药物、以及使用这种化合物治疗或预防与酶神经鞘糖脂转移酶（CGT）相关的疾病或紊乱的方法，例如溶酶体贮积症。溶酶体贮积症的例子包括 Krabbe 病和白质变性白血病。
• [EN] 5-SULFAMOYL-2-HYDROXYBENZAMIDE DERIVATIVES<br/>[FR] DÉRIVÉS DE 5-SULFAMOYL-2-HYDROXYBENZAMIDE
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2017153952A1

  公开（公告）日：2017-09-14

  The invention is directed to substituted salicylamide derivatives. Specifically, the invention is directed to compounds according to Formula (I): wherein R, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof. The compounds of the invention are inhibitors of CD73 and can be useful in the treatment of cancer, pre-cancerous syndromes and diseases associated with CD73 inhibition, such as AIDS, the treatment of HIV, autoimmune diseases, infections, atherosclerosis, and ischemia–reperfusion injury. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CD73 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

  本发明涉及取代水杨酰胺衍生物。具体而言，本发明涉及根据公式(I)的化合物：其中R、R1和R2如本文所述，或其药用可接受的盐。本发明的化合物是CD73的抑制剂，可用于治疗癌症、前癌症综合症以及与CD73抑制相关的疾病，例如艾滋病、治疗HIV、自身免疫疾病、感染、动脉粥样硬化和缺血再灌注损伤。因此，本发明进一步涉及包含本发明化合物的药物组合物。本发明还进一步涉及使用本发明化合物或包含本发明化合物的药物组合物来抑制CD73活性和治疗与之相关的疾病的方法。
• [EN] INHIBITORS OF BRUTON'S TYROSINE KINASE<br/>[FR] INHIBITEURS DE LA TYROSINE KINASE DE BRUTON
  申请人：HOFFMANN LA ROCHE

  公开号：WO2015086636A1

  公开（公告）日：2015-06-18

  This application discloses compounds according to generic Formula (I): wherein all variables are defined as described herein, which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are useful for the treatment of oncological, auto-immune, and inflammatory diseases caused by aberrant B-cell activation. Also disclosed are compositions containing compounds of Formula I and at least one carrier, diluent or excipient.

  该应用程序根据通用公式（I）披露化合物：其中所有变量的定义如本文所述，这些化合物抑制Btk。本文披露的化合物对调节Btk的活性并治疗与过度Btk活性相关的疾病有用。这些化合物对于治疗由异常B细胞活化引起的肿瘤学、自身免疫和炎症性疾病是有用的。还披露了含有公式I化合物和至少一种载体、稀释剂或赋形剂的组合物。
• Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments
  申请人：Schwink Lothar

  公开号：US20050176795A1

  公开（公告）日：2005-08-11

  The invention relates to substituted N-cyclohexylheterocycles and to the physiologically tolerated salts and physiologically functional derivatives thereof, to processes for their preparation and to their use as medicaments. Compounds of the formula I, in which the radicals have the stated meanings, and the physiologically tolerated salts thereof, and process for their preparation are described. The compounds bring about for example a weight reduction in mammals and are suitable for example for the prevention and treatment of obesity and diabetes.

  本发明涉及替代N-环己基杂环化合物以及其生理耐受盐和生理功能衍生物，涉及它们的制备过程以及它们作为药物的用途。描述了具有以下结构的化合物I，其中基团具有所述含义，以及其生理耐受盐和制备过程。这些化合物例如可导致哺乳动物体重减轻，并且例如适用于肥胖和糖尿病的预防和治疗。
• Formation of nitrophenyl ethers from polyols and nitroanisoles
  申请人：THE DOW CHEMICAL COMPANY

  公开号：EP0335274A2

  公开（公告）日：1989-10-04

  Disclosed is a novel process for effecting an ether interchange reaction by heating together in the presence of a basic catalyst, a nitroaromatic ether or thioether and an organic compound containing at least one hydroxyl or mercapto group. The novelty resides particularly in carrying out the interchange in an inert solvent while sparging the heated reactants thereby to remove at least a portion of solvent along with an evolving alcohol or thiol. The process is particularly adapted to the capping of organic polyols with nitroaromatic ether groups. The capped products are useful as inter­mediates for the preparation of high molecular weight polyamines which in turn find utility in various polymer applications.

  本发明公开了一种新工艺，在碱性催化剂存在下，将硝基芳香族醚或硫醚和含有至少一个羟基或巯基的有机化合物一起加热，从而进行醚互换反应。新颖之处尤其在于在惰性溶剂中进行交换反应，同时对加热的反应物进行喷射，以除去至少一部分溶剂和挥发的醇或硫醇。 该工艺特别适用于有机多元醇与硝基芳香族醚基团的封端。封端的产品可用作制备高分子量多胺的中间体，而高分子量多胺又可用于各种聚合物应用。